BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aloia TA, Adam R, Azoulay D, Bismuth H, Castaing D. Outcome following hepatic resection of metastatic renal tumors: the Paul Brousse Hospital experience. HPB (Oxford). 2006;8:100-105. [PMID: 18333255 DOI: 10.1080/13651820500496266] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Kim DY, Karam JA, Wood CG. Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy. World J Urol 2014;32:631-42. [DOI: 10.1007/s00345-014-1293-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
2 Ruiz-Cerdá JL, Jiménez Cruz F. [Surgical treatment for renal cancer metastases]. Actas Urol Esp 2009;33:593-602. [PMID: 19658314 DOI: 10.1016/s0210-4806(09)74194-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Yopp AC, Shia J, Butte JM, Allen PJ, Fong Y, Jarnagin WR, DeMatteo RP, D'Angelica MI. CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2012;19 Suppl 3:S339-S346. [PMID: 21584832 DOI: 10.1245/s10434-011-1774-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
4 Hess J, vom Dorp F, Becker M, Rübben H, Börgermann C. [Impact of surgery for residual tumors after chemotherapy]. Urologe A 2009;48:73-8. [PMID: 19066839 DOI: 10.1007/s00120-008-1756-8] [Reference Citation Analysis]
5 Abdelmaksoud MH, Louie JD, Hwang GL, Kothary N, Minor DR, Sze DY. Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver. J Vasc Interv Radiol. 2012;23:323-330.e1. [PMID: 22277275 DOI: 10.1016/j.jvir.2011.11.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
6 Brehmer B, Piper C, Pfister D, Porres D, Heidenreich A. [Metastasectomy for renal cell cancer]. Urologe A 2012;51:1202-8. [PMID: 22733397 DOI: 10.1007/s00120-012-2872-z] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
7 Pinotti E, Montuori M, Giani A, Uggeri F, Garancini M, Gianotti L, Romano F. Surgical treatment of liver metastases from kidney cancer: a systematic review. ANZ J Surg. 2019;89:32-37. [PMID: 30685878 DOI: 10.1111/ans.15000] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
8 Fleckenstein FN, Schernthaner RE, Duran R, Sohn JH, Sahu S, Marshall K, Lin M, Gebauer B, Chapiro J, Salem R, Geschwind JF. Renal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis. Transl Oncol 2016;9:377-83. [PMID: 27641641 DOI: 10.1016/j.tranon.2016.07.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kis B, Shah J, Choi J, El-Haddad G, Sweeney J, Biebel B, Mellon E, Frakes JM, Hoffe SE, Fishman MN, Shridhar R. Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma. J Vasc Interv Radiol 2017;28:254-9. [PMID: 27955832 DOI: 10.1016/j.jvir.2016.09.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
10 Langan RC, Ripley RT, Davis JL, Prieto PA, Datrice N, Steinberg SM, Bratslavsky G, Rudloff U, Kammula US, Stojadinovic A. Liver directed therapy for renal cell carcinoma. J Cancer. 2012;3:184-190. [PMID: 22558019 DOI: 10.7150/jca.4456] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
11 Hatzaras I, Gleisner AL, Pulitano C, Sandroussi C, Hirose K, Hyder O, Wolfgang CL, Aldrighetti L, Crawford M, Choti MA, Pawlik TM. A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB (Oxford). 2012;14:532-538. [PMID: 22762401 DOI: 10.1111/j.1477-2574.2012.00495.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
12 Martel G, Bertens KA, Canil C. Surgical Management of Genitourinary Cancer Liver Metastases. Surg Oncol Clin N Am 2021;30:89-102. [PMID: 33220811 DOI: 10.1016/j.soc.2020.08.003] [Reference Citation Analysis]
13 Chatzizacharias NA, Rosich-Medina A, Dajani K, Harper S, Huguet E, Liau SS, Praseedom RK, Jah A. Surgical management of hepato-pancreatic metastasis from renal cell carcinoma. World J Gastrointest Oncol 2017; 9(2): 70-77 [PMID: 28255428 DOI: 10.4251/wjgo.v9.i2.70] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
14 Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Tabernero J, Teh C, Van Cutsem E;  Jean-Nicolas Vauthey of the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012;17:1225-1239. [PMID: 22962059 DOI: 10.1634/theoncologist.2012-0121] [Cited by in Crossref: 284] [Cited by in F6Publishing: 255] [Article Influence: 28.4] [Reference Citation Analysis]
15 Wei D. Surgical treatment of low rectal cancer: Current status and future prospects. Shijie Huaren Xiaohua Zazhi 2016; 24(21): 3238-3247 [DOI: 10.11569/wcjd.v24.i21.3238] [Reference Citation Analysis]
16 Neri F, Ercolani G, Di Gioia P, Del Gaudio M, Pinna AD. Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature. Updates Surg 2015;67:223-33. [PMID: 26341625 DOI: 10.1007/s13304-015-0315-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
17 Geisel D, Collettini F, Denecke T, Grieser C, Flörcken A, Wust P, Hamm B, Gebauer B. Treatment for liver metastasis from renal cell carcinoma with computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT): a case series. World J Urol 2013;31:1525-30. [PMID: 23132612 DOI: 10.1007/s00345-012-0981-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
18 Thomas AZ, Adibi M, Borregales LD, Wood CG, Karam JA. Role of metastasectomy in metastatic renal cell carcinoma. Current Opinion in Urology 2015;25:381-9. [DOI: 10.1097/mou.0000000000000196] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
19 Kim SH, Kim JK, Park EY, Joo J, Lee KH, Seo HK, Joung JY, Chung J. Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy. PLoS One 2019;14:e0211105. [PMID: 30785902 DOI: 10.1371/journal.pone.0211105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Hahn O, Dudás I, Pajor P, Györke T, Korom C, Zsirka-Klein A, Kupcsulik P, Harsányi L. [ALPPS (Associated Liver Partition and Portal vein ligation for Staged hepatectomy) -- faster and greater growth of liver]. Magy Seb. 2013;66:21-26. [PMID: 23428724 DOI: 10.1556/maseb.66.2013.1.3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
21 Beetz O, Söffker R, Cammann S, Oldhafer F, Vondran FWR, Imkamp F, Klempnauer J, Kleine M. Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades. Langenbecks Arch Surg 2020;405:97-106. [PMID: 31938833 DOI: 10.1007/s00423-019-01852-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Kuei A, Saab S, Cho SK, Kee ST, Lee EW. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors. World J Gastroenterol 2015; 21(27): 8271-8283 [PMID: 26217079 DOI: 10.3748/wjg.v21.i27.8271] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
23 Navarro-Freire F, Navarro-Sánchez P, García-Agua N, Pérez-Cabrera B, Palomeque-Jiménez A, Jiménez-Rios JA, García-López PA, García-Ruiz AJ. Effectiveness of surgery in liver metastasis from colorectal cancer: experience and results of a continuous improvement process. Clin Transl Oncol 2015;17:547-56. [PMID: 25775916 DOI: 10.1007/s12094-015-1277-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Heidenreich A, Wilop S, Pinkawa M, Porres D, Pfister D. Surgical resection of urological tumor metastases following medical treatment. Dtsch Arztebl Int 2012;109:631-7. [PMID: 23093995 DOI: 10.3238/arztebl.2012.0631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
25 Ruys AT, Tanis PJ, Nagtegaal ID, van Duijvendijk P, Verhoef C, Porte RJ, van Gulik TM. Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann Surg Oncol. 2011;18:1932-1938. [PMID: 21347794 DOI: 10.1245/s10434-010-1526-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
26 Brufau BP, Cerqueda CS, Villalba LB, Izquierdo RS, González BM, Molina CN. Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT. Radiographics 2013;33:1691-716. [PMID: 24108558 DOI: 10.1148/rg.336125110] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 9.6] [Reference Citation Analysis]
27 Loh J, Davis ID, Martin JM, Siva S. Extracranial oligometastatic renal cell carcinoma: current management and future directions. Future Oncol 2014;10:761-74. [PMID: 24799057 DOI: 10.2217/fon.14.40] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
28 Patrlj L, Kopljar M, Kliček R, Patrlj MH, Kolovrat M, Rakić M, Duzel A. The surgical treatment of patients with colorectal cancer and liver metastases in the setting of the "liver first" approach. Hepatobiliary Surg Nutr 2014;3:324-9. [PMID: 25392845 DOI: 10.3978/j.issn.2304-3881.2014.09.12] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
29 Grimes NG, Devlin JM, Dunne DF, Jones RP, Poston GJ, Fenwick SW, Malik HZ. A systematic review of the role of hepatectomy in the management of metastatic renal cell carcinoma. Eur J Surg Oncol. 2014;40:1622-1628. [PMID: 25228053 DOI: 10.1016/j.ejso.2014.08.472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
30 Hau HM, Thalmann F, Lübbert C, Morgul MH, Schmelzle M, Atanasov G, Benzing C, Lange U, Ascherl R, Ganzer R, Uhlmann D, Tautenhahn HM, Wiltberger G, Bartels M. The value of hepatic resection in metastasic renal cancer in the Era of Tyrosinkinase Inhibitor Therapy. BMC Surg 2016;16:49. [PMID: 27444582 DOI: 10.1186/s12893-016-0163-0] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]